Form 4 for BLFS BIOLIFE SOLUTIONS INC
Accepted 2022-09-01 00:00:00 ET · period of report 2022-08-31 · accession 0001437749-22-021729 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-09-01 | 2022-08-31 | BLFS | Rice Michael | CEO, Dir | S - Sale | $23.44 | -906 | 363.1K | -0.2% | -$21.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-08-31 | S | D | 906 | $23.44 | 363,148 | D | — | — |